relative to prescription medication for treatment or prevention of communicable disease.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 4 Sponsors 4

Jun 16, 2020

Vacated from Committee and Laid on Table, MA, VV; 06/16/2020 SJ 8

Mar 12, 2020

==CANCELLED==,Hearing: 03/17/2020, Room 101, LOB, 01:15 pm, on proposed amendment # 2020-1212s; SC 11

Feb 20, 2020

==CANCELLED== Hearing: 03/17/2020, Room 101, LOB, 01:00 pm; SC 11

Jan 8, 2020

To Be Introduced 01/08/2020 and Referred to Health and Human Services; SJ 1

PASSAGE PROBABILITY

15.7% Unlikely

Why this number

Stage base In Committee — base rate 27%, measured from NH's completed sessions
Momentum -2 40/100 from the pace of recorded action
Time since last action -22 2307 days quiet
Cosponsors +4 3 signed on
Bipartisan support +9 3 D · 1 R

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.